Spotlight
The CareFusion Foundation today announced the recipients of more than $500,000 in grant funding to help develop and share infection prevention best practices.
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced it has received the 2013 Confirmit ACE (Achievement in Customer Excellence) Award, demonstrating CareFusion’s long-term commitment to customer service and support for medical technologies.
Revenue of $901 million in line with company expectations.
Children’s Hospitals and Clinics of Minnesota was honored with the Way Paver Award for Institutional Achievement at this year’s unSUMMIT conference on April 24 in Orlando, Fla.
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation product and its relationships with health care professionals.
CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2013 results on Thursday, May 9, following the close of trading on the New York Stock Exchange.
CareFusion Corp. (NYSE: CFN) today announced a private offering of $300 million aggregate principal amount of senior notes, the net proceeds of which the company intends to use for general corporate purposes.
Combined Technology from Stanley Healthcare and CareFusion Creates Solution for Near Real-Time Location and Utilization Data of IV Pumps
Snowden-Pencer® instruments facilitate sterilization, enhance ergonomics and performance
Read more >